| Bid Price | 0.65p | High Price | 0.80p |
|---|
| Ask Price | 0.70p | Low Price | 0.65p |
|---|
| Open Price | 0.75p | Spread | 7.14% |
|---|
| Prev Close | 0.75p | Volume | 17,077,699 |
|---|
Genflow Biosciences PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jul 9, 2025 | 0.75 | 0.80 | 0.65 | 0.68 | 17,077,699 |
| Jul 8, 2025 | 0.80 | 0.90 | 0.72 | 0.75 | 19,590,699 |
| Jul 7, 2025 | 0.68 | 0.83 | 0.65 | 0.80 | 53,389,981 |
| Jul 4, 2025 | 0.72 | 0.72 | 0.65 | 0.68 | 7,535,628 |
| Jul 3, 2025 | 0.72 | 0.75 | 0.70 | 0.72 | 1,114,669 |
Genflow Biosciences PLC Information
| Name | Genflow Biosciences PLC | Index | |
|---|
| ISIN | GB00BP2C3V08 | Epic | GENF |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 200,000 | Trading Status | Closed |
|---|
| Shares in Issue | 453.55 m | Prev Close | 0.75p |
|---|
| PE Ratio | | Market Cap | £3.06 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -4.668964 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.486542 | Quick Ratio | 0.359266 |
|---|
Genflow Biosciences PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 15/05/25 | PLAC | Eric Leire | CEO | 62,500,000 @ £0.01 | £500,000.00 |
| 28/03/25 | BUY | Eric Leire | CEO | 2,100,000 @ £0.01 | £24,150.00 |
| 15/08/22 | BUY | Eric Leire | CEO | 106,000 @ £0.03 | £2,968.00 |
| 20/07/22 | BUY | Yassine Bendiabdallah | CH | 108,000 @ £0.04 | £3,996.00 |
| 20/07/22 | BUY | Peter King-Lewis | NED | 82,000 @ £0.04 | £3,034.00 |
| 19/07/22 | BUY | Eric Leire | CEO | 308,999 @ £0.03 | £9,363.00 |
Genflow Biosciences PLC News
